KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014

One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiven...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Ida Nurlaelah [verfasserIn] Alwiyah Mukaddas [verfasserIn] Ingrid Faustine [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch ; Indonesisch

Erschienen:	2015

Schlagwörter:	Drug interactions, Diabetes melitus Hypertension, Pharmacodynamic drug interaction

Übergeordnetes Werk:	In: Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) - Universitas Tadulako, 2018, 1(2015), 1, Seite 35-41
Übergeordnetes Werk:	volume:1 ; year:2015 ; number:1 ; pages:35-41

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.22487/j24428744.2015.v1.i1.4833

Katalog-ID:	DOAJ00138631X

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ00138631X
003	DE-627
005	20230502072828.0
007	cr uuu---uuuuu
008	230225s2015 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.22487/j24428744.2015.v1.i1.4833 \|2 doi
035			\|a (DE-627)DOAJ00138631X
035			\|a (DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng \|a ind
050		0	\|a RM1-950
100	0		\|a Ida Nurlaelah \|e verfasserin \|4 aut
245	1	0	\|a KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014
264		1	\|c 2015
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions
650		4	\|a Drug interactions, Diabetes melitus
650		4	\|a Hypertension, Pharmacodynamic drug interaction
653		0	\|a Therapeutics. Pharmacology
700	0		\|a Alwiyah Mukaddas \|e verfasserin \|4 aut
700	0		\|a Ingrid Faustine \|e verfasserin \|4 aut
773	0	8	\|i In \|t Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) \|d Universitas Tadulako, 2018 \|g 1(2015), 1, Seite 35-41 \|w (DE-627)1760615722 \|x 24428744 \|7 nnns
773	1	8	\|g volume:1 \|g year:2015 \|g number:1 \|g pages:35-41
856	4	0	\|u https://doi.org/10.22487/j24428744.2015.v1.i1.4833 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d \|z kostenfrei
856	4	0	\|u http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2442-7284 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2442-8744 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a SSG-OLC-PHA
951			\|a AR
952			\|d 1 \|j 2015 \|e 1 \|h 35-41

Indexfelder

author_variant	i n in a m am i f if
matchkey_str	article:24428744:2015----::ainneasoapdpnoaadaeemltsmegnietniintlsrwtaaru
hierarchy_sort_str	2015
callnumber-subject-code	RM
publishDate	2015
allfields	10.22487/j24428744.2015.v1.i1.4833 doi (DE-627)DOAJ00138631X (DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d DE-627 ger DE-627 rakwb eng ind RM1-950 Ida Nurlaelah verfasserin aut KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions Drug interactions, Diabetes melitus Hypertension, Pharmacodynamic drug interaction Therapeutics. Pharmacology Alwiyah Mukaddas verfasserin aut Ingrid Faustine verfasserin aut In Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Universitas Tadulako, 2018 1(2015), 1, Seite 35-41 (DE-627)1760615722 24428744 nnns volume:1 year:2015 number:1 pages:35-41 https://doi.org/10.22487/j24428744.2015.v1.i1.4833 kostenfrei https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d kostenfrei http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833 kostenfrei https://doaj.org/toc/2442-7284 Journal toc kostenfrei https://doaj.org/toc/2442-8744 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 1 2015 1 35-41
spelling	10.22487/j24428744.2015.v1.i1.4833 doi (DE-627)DOAJ00138631X (DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d DE-627 ger DE-627 rakwb eng ind RM1-950 Ida Nurlaelah verfasserin aut KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions Drug interactions, Diabetes melitus Hypertension, Pharmacodynamic drug interaction Therapeutics. Pharmacology Alwiyah Mukaddas verfasserin aut Ingrid Faustine verfasserin aut In Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Universitas Tadulako, 2018 1(2015), 1, Seite 35-41 (DE-627)1760615722 24428744 nnns volume:1 year:2015 number:1 pages:35-41 https://doi.org/10.22487/j24428744.2015.v1.i1.4833 kostenfrei https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d kostenfrei http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833 kostenfrei https://doaj.org/toc/2442-7284 Journal toc kostenfrei https://doaj.org/toc/2442-8744 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 1 2015 1 35-41
allfields_unstemmed	10.22487/j24428744.2015.v1.i1.4833 doi (DE-627)DOAJ00138631X (DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d DE-627 ger DE-627 rakwb eng ind RM1-950 Ida Nurlaelah verfasserin aut KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions Drug interactions, Diabetes melitus Hypertension, Pharmacodynamic drug interaction Therapeutics. Pharmacology Alwiyah Mukaddas verfasserin aut Ingrid Faustine verfasserin aut In Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Universitas Tadulako, 2018 1(2015), 1, Seite 35-41 (DE-627)1760615722 24428744 nnns volume:1 year:2015 number:1 pages:35-41 https://doi.org/10.22487/j24428744.2015.v1.i1.4833 kostenfrei https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d kostenfrei http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833 kostenfrei https://doaj.org/toc/2442-7284 Journal toc kostenfrei https://doaj.org/toc/2442-8744 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 1 2015 1 35-41
allfieldsGer	10.22487/j24428744.2015.v1.i1.4833 doi (DE-627)DOAJ00138631X (DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d DE-627 ger DE-627 rakwb eng ind RM1-950 Ida Nurlaelah verfasserin aut KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions Drug interactions, Diabetes melitus Hypertension, Pharmacodynamic drug interaction Therapeutics. Pharmacology Alwiyah Mukaddas verfasserin aut Ingrid Faustine verfasserin aut In Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Universitas Tadulako, 2018 1(2015), 1, Seite 35-41 (DE-627)1760615722 24428744 nnns volume:1 year:2015 number:1 pages:35-41 https://doi.org/10.22487/j24428744.2015.v1.i1.4833 kostenfrei https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d kostenfrei http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833 kostenfrei https://doaj.org/toc/2442-7284 Journal toc kostenfrei https://doaj.org/toc/2442-8744 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 1 2015 1 35-41
allfieldsSound	10.22487/j24428744.2015.v1.i1.4833 doi (DE-627)DOAJ00138631X (DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d DE-627 ger DE-627 rakwb eng ind RM1-950 Ida Nurlaelah verfasserin aut KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions Drug interactions, Diabetes melitus Hypertension, Pharmacodynamic drug interaction Therapeutics. Pharmacology Alwiyah Mukaddas verfasserin aut Ingrid Faustine verfasserin aut In Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Universitas Tadulako, 2018 1(2015), 1, Seite 35-41 (DE-627)1760615722 24428744 nnns volume:1 year:2015 number:1 pages:35-41 https://doi.org/10.22487/j24428744.2015.v1.i1.4833 kostenfrei https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d kostenfrei http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833 kostenfrei https://doaj.org/toc/2442-7284 Journal toc kostenfrei https://doaj.org/toc/2442-8744 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 1 2015 1 35-41
language	English Indonesian
source	In Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) 1(2015), 1, Seite 35-41 volume:1 year:2015 number:1 pages:35-41
sourceStr	In Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) 1(2015), 1, Seite 35-41 volume:1 year:2015 number:1 pages:35-41
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Drug interactions, Diabetes melitus Hypertension, Pharmacodynamic drug interaction Therapeutics. Pharmacology
isfreeaccess_bool	true
container_title	Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)
authorswithroles_txt_mv	Ida Nurlaelah @@aut@@ Alwiyah Mukaddas @@aut@@ Ingrid Faustine @@aut@@
publishDateDaySort_date	2015-01-01T00:00:00Z
hierarchy_top_id	1760615722
id	DOAJ00138631X
language_de	englisch Sangiang
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ00138631X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502072828.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.22487/j24428744.2015.v1.i1.4833</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ00138631X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">ind</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ida Nurlaelah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug interactions, Diabetes melitus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension, Pharmacodynamic drug interaction</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alwiyah Mukaddas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ingrid Faustine</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)</subfield><subfield code="d">Universitas Tadulako, 2018</subfield><subfield code="g">1(2015), 1, Seite 35-41</subfield><subfield code="w">(DE-627)1760615722</subfield><subfield code="x">24428744</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:35-41</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.22487/j24428744.2015.v1.i1.4833</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2442-7284</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2442-8744</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield><subfield code="h">35-41</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Ida Nurlaelah
spellingShingle	Ida Nurlaelah misc RM1-950 misc Drug interactions, Diabetes melitus misc Hypertension, Pharmacodynamic drug interaction misc Therapeutics. Pharmacology KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014
authorStr	Ida Nurlaelah
ppnlink_with_tag_str_mv	@@773@@(DE-627)1760615722
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RM1-950
illustrated	Not Illustrated
issn	24428744
topic_title	RM1-950 KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014 Drug interactions, Diabetes melitus Hypertension, Pharmacodynamic drug interaction
topic	misc RM1-950 misc Drug interactions, Diabetes melitus misc Hypertension, Pharmacodynamic drug interaction misc Therapeutics. Pharmacology
topic_unstemmed	misc RM1-950 misc Drug interactions, Diabetes melitus misc Hypertension, Pharmacodynamic drug interaction misc Therapeutics. Pharmacology
topic_browse	misc RM1-950 misc Drug interactions, Diabetes melitus misc Hypertension, Pharmacodynamic drug interaction misc Therapeutics. Pharmacology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)
hierarchy_parent_id	1760615722
hierarchy_top_title	Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1760615722
title	KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014
ctrlnum	(DE-627)DOAJ00138631X (DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d
title_full	KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014
author_sort	Ida Nurlaelah
journal	Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)
journalStr	Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)
callnumber-first-code	R
lang_code	eng ind
isOA_bool	true
recordtype	marc
publishDateSort	2015
contenttype_str_mv	txt
container_start_page	35
author_browse	Ida Nurlaelah Alwiyah Mukaddas Ingrid Faustine
container_volume	1
class	RM1-950
format_se	Elektronische Aufsätze
author-letter	Ida Nurlaelah
doi_str_mv	10.22487/j24428744.2015.v1.i1.4833
author2-role	verfasserin
title_sort	kajian interaksi obat pada pengobatan diabetes melitus (dm) dengan hipertensi di instalasi rawat jalan rsud undata periode maret-juni tahun 2014
callnumber	RM1-950
title_auth	KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014
abstract	One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions
abstractGer	One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions
abstract_unstemmed	One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA
container_issue	1
title_short	KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014
url	https://doi.org/10.22487/j24428744.2015.v1.i1.4833 https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833 https://doaj.org/toc/2442-7284 https://doaj.org/toc/2442-8744
remote_bool	true
author2	Alwiyah Mukaddas Ingrid Faustine
author2Str	Alwiyah Mukaddas Ingrid Faustine
ppnlink	1760615722
callnumber-subject	RM - Therapeutics and Pharmacology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.22487/j24428744.2015.v1.i1.4833
callnumber-a	RM1-950
up_date	2024-07-03T20:07:28.284Z
_version_	1803589777658740736
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ00138631X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502072828.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.22487/j24428744.2015.v1.i1.4833</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ00138631X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJa9dfe115f5ce4a20ad1687043142568d</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">ind</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ida Nurlaelah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">One of the chronic complications of diabetes mellitus is a disorder of macrovascular as hypertension so that in it’s medicinal treatment required therapy with multiple drugs all at once that can lead to drug interactions. Drug interactions can result in increased toxicity and decrease the effectiveness of drugs that interact. This study aims to determine the prescription profile of DM patients with hypertension include the number of drugs prescribed, dosage forms, classes and types of drugs and the incidence of drug interactions theoretically, based on the mechanism drug interactions in outpatient installations of RSUD Undata Palu 2014. This design research is a non-experimental study with descriptive. Retrieval of patient data performed prospectively during the period from March to June 2014. Subjects who fill the inclusion criteria is adult patients that attain age of 18-60 years and diagnosed diabetes mellitus with hypertension are interview to obtain primary data while the secondary data such as medical records and prescriptions. Retrieved 61 sample. Based on dosage forms prescribe profile that most often given to the DM patients with hypertension was tablets (94.5%). Class of diabetes drugs most widely used is a sulfonylurea (21.1%) and hypertension drug classes beta blocker (12.2%). Types of diabetic drugs most widely used was glimepiride (14.2%) and hypertension was bisoprolol (9.2%). The percentage result of drug interactions theoretically was 85.2% (52 patients), drug interactions type that the most occured was pharmacodynamic interactions 72.7%. Diabetes melitus Patients with hypertension in outpatient installations of RSUD Undata Palu 2014 were most potentially subjected to drug interactions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug interactions, Diabetes melitus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension, Pharmacodynamic drug interaction</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alwiyah Mukaddas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ingrid Faustine</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)</subfield><subfield code="d">Universitas Tadulako, 2018</subfield><subfield code="g">1(2015), 1, Seite 35-41</subfield><subfield code="w">(DE-627)1760615722</subfield><subfield code="x">24428744</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:35-41</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.22487/j24428744.2015.v1.i1.4833</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/a9dfe115f5ce4a20ad1687043142568d</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/4833</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2442-7284</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2442-8744</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield><subfield code="h">35-41</subfield></datafield></record></collection>
score	7.3985367

Nicht das Richtige dabei?

Schreiben Sie uns!

KAJIAN INTERAKSI OBAT PADA PENGOBATAN DIABETES MELITUS (DM) DENGAN HIPERTENSI DI INSTALASI RAWAT JALAN RSUD UNDATA PERIODE MARET-JUNI TAHUN 2014

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?